课题基金 / 基金详情

The Role of HB-EGF in Renal Epithelial Cell Injury

The Role of HB-EGF in Renal Epithelial Cell Injury
HB-EGF 在肾上皮细胞损伤中的作用
批准号:
6872550
负责人:
RAYMOND C. HARRIS
金额:
$33.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-15 至 2009-12-31

项目摘要

项目成果

RAYMOND C. HARRIS的其他基金

相似基金

相关文献

中文摘要
翻译
越来越多的证据表明,EGF受体(EGFR;HER1)的激活在急性肾损伤的恢复中发挥了作用。肝素结合的表皮生长因子(HB-EGF)通过EGFR和HER4在哺乳动物肾脏中表达,作为对急性损伤的反应。可溶性HB-EGF的前体为膜相关HB-EGF(proHB-EGF)。我们推测,在肾上皮细胞中,proHB-EGF介导的细胞功能不同于可溶性HB-EGF。我们认为,proHBEGF通过以下途径帮助维持上皮细胞的极性、完整性和分化:1)通过EGFR和/或HER4的旁分泌信号;2)作为促进细胞-细胞相互作用的膜相关和细胞骨架元件(四环素、整合素和糖蛋白)的支架。因此,ProHB-EGF的切割可能通过释放可作为自分泌和旁分泌生长因子的可溶性HB-EGF,以及通过破坏ProHB-EGF及其相关蛋白的细胞-细胞、细胞-ECM和细胞骨架相互作用而导致细胞激活,从而使上皮细胞易于运动、增殖和去分化。具体目标#1将研究前HBEGF激活旁分泌在调节上皮细胞-细胞相互作用中的作用。具体目标#2将确定ProHBEGF与四环素整合素网络和含硫酸肝素糖蛋白的相互作用在调节细胞-基质和细胞-细胞相互作用中的作用。具体目标#3将研究proHB-EGF保护肾上皮细胞免于凋亡的机制。对于特定的目标#1-3,我们将利用前HB-EGF分子的突变和嵌合体来区分EGFR激活、肝素结合、Tetraspanin相互作用和胞浆蛋白相互作用。特定目的#4将利用表达FLOXED HB-EGF的小鼠与表达靶向肾单位片段特异性Cre重组酶的小鼠以及在近端肾单位过表达HB-EGF的转基因小鼠杂交,以检测HB-EGF表达的改变对急性和进行性肾脏损伤反应的影响。
英文摘要
There is increasing evidence for a role for EGF receptor (EGFR; HER1) activation in recovery from acute renal injury. Expression of heparin-binding epidermal growth factor (HB-EGF), which signals through EGFR as well as HER4, increases in the mammalian kidney in response to acute injury. The precursor for soluble HB-EGF is membrane-associated HB-EGF (proHB-EGF). We hypothesize that in renal epithelial cells, proHB-EGF mediates different cellular functions than soluble HB-EGF. We propose that proHBEGF helps to maintain epithelial cell polarity, integrity and differentiation by: 1) juxtacrine signaling through EGFR and/or HER4; and 2) serving as a scaffold for membrane-associated and cytoskeletal elements (tetraspanins, integrins and glycoproteins) that promote cell-cell interactions. Therefore, cleavage of proHB-EGF may lead to cell activation by release of soluble HB-EGF that can serve as an autocrine and paracrine growth factor as well as by disruption of cell-cell, cell-ECM and cytoskeletal interactions of proHB-EGF and associated proteins that predispose the epithelial cells to motility, proliferation and dedifferentiation. Specific Aim #1 will study the role of juxtacrine activation by proHBEGF in mediation of epithelial cell-cell interactions. Specific Aim #2 will determine the role of proHBEGF's interactions with the tetraspanin-integrin web and with heparin sulfate-containing glycoproteins in mediation of cell-matrix and cell-cell interactions. Specific Aim #3 will investigate the mechanisms by which proHB-EGF protects renal epithelial cells against apoptosis. For Specific Aims #1-3, we will utilize mutations and chimeras of the proHB-EGF molecule that will discriminate among EGFR activation, heparin binding, tetraspanin interaction and cytosolic protein interactions. Specific Aim #4 will utilize crosses of mice expressing floxed HB-EGF with mice expressing targeted nephron segment specific Cre recombinase, as well as transgenic mice overexpressing HB-EGF in proximal nephron, to examine the effects of altered HB-EGF expression on kidney responses to acute and progressive injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
Organ Specific Project - Kidney
  • 批准号:
    10201589
  • 项目类别:
  • 资助金额:
    $115.85万
  • 财政年份:
    2018
  • 负责人:
    RAYMOND C. HARRIS
  • 依托单位:
Vanderbilt O'Brien Kidney Center-Administrative Core
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: